SCHEMBL29564142

SCHEMBL29564142

O=C(N1CCNCC1)N1CCSc2ccc(OC(F)(F)F)cc2C1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RYR2 Q92736 20/20 0.74
KCNH2 Q12809 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24460353 1.00 RYR2 (0.74) RYR2KCNH2
Hydrochloric Acid SCHEMBL29563669 0.99 RYR2 (0.73) RYR2KCNH2
SCHEMBL26942217 0.89 RYR2 (0.73) RYR2KCNH2
SCHEMBL6866991 0.85 RYR2 (1.00) RYR2KCNH2
SCHEMBL24460327 0.83 RYR2 (0.65) RYR2KCNH2
SCHEMBL29563318 0.83 RYR2 (0.65) RYR2KCNH2
Hydrochloric Acid SCHEMBL29563284 0.82 RYR2 (0.64) RYR2KCNH2
SCHEMBL24460451 0.82 RYR2 (0.53) RYR2
SCHEMBL26942271 0.79 RYR2 (0.73) RYR2KCNH2
SCHEMBL10070492 0.78 RYR2 (0.46) RYR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024086819-A2 DIAGNOSIS AND TREATMENT OF HEART FAILURE ARMGO PHARMA, INC. (US) 2024-04-25 WO disclosed
EP-4247778-A1 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS Armgo Pharma, Inc. (US) 2023-09-27 EP disclosed
WO-2022108945-A1 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2022-05-27 WO disclosed